Christopher Gibson - 14 Apr 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
14 Apr 2022
Net transactions value
-$170,485
Form type
4
Filing time
18 Apr 2022, 21:46:29 UTC
Previous filing
12 Apr 2022
Next filing
20 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Options Exercise $109,145 +44,010 +13% $2.48 384,134 14 Apr 2022 Direct F1
transaction RXRX Class A Common Stock Sale $121,989 -16,017 -4.2% $7.62 368,117 14 Apr 2022 Direct F1, F2
transaction RXRX Class A Common Stock Conversion of derivative security $0 +18,500 +5% $0.000000 386,617 14 Apr 2022 Direct F1, F3, F4
transaction RXRX Class A Common Stock Sale $138,874 -18,500 -4.8% $7.51 368,117 14 Apr 2022 Direct F1, F5
transaction RXRX Class A Common Stock Conversion of derivative security $0 +500 $0.000000 500 14 Apr 2022 by LAHWRAN-3 LLC F1, F3, F4
transaction RXRX Class A Common Stock Sale $3,750 -500 -100% $7.50 0 14 Apr 2022 by LAHWRAN-3 LLC F1, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 14 Apr 2022 by LAHWRAN-4 LLC F1, F3, F4
transaction RXRX Class A Common Stock Sale $7,505 -1,000 -100% $7.51 0 14 Apr 2022 by LAHWRAN-4 LLC F1, F6
transaction RXRX Class A Common Stock Conversion of derivative security $0 +1,000 $0.000000 1,000 14 Apr 2022 by Gibson Family Trust F1, F3, F4
transaction RXRX Class A Common Stock Sale $7,512 -1,000 -100% $7.51 0 14 Apr 2022 by Gibson Family Trust F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Class B Common Stock Conversion of derivative security $0 -18,500 -0.27% $0.000000 6,948,334 14 Apr 2022 Class A Common Stock 6,948,334 $0.000000 Direct F1, F3, F4
transaction RXRX Stock Option (Right to Buy) Options Exercise $0 -44,010 -3.4% $0.000000 1,251,304 14 Apr 2022 Class A Common Stock 1,251,304 $2.48 Direct F1, F8
transaction RXRX Class B Common Stock Conversion of derivative security $0 -500 -0.09% $0.000000 547,500 14 Apr 2022 Class A Common Stock 547,500 $0.000000 by LAHWRAN-3 LLC F1, F3, F4, F9
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.18% $0.000000 545,000 14 Apr 2022 Class A Common Stock 545,000 $0.000000 by LAHWRAN-4 LLC F1, F3, F4, F10
transaction RXRX Class B Common Stock Conversion of derivative security $0 -1,000 -0.7% $0.000000 141,875 14 Apr 2022 Class A Common Stock 141,875 $0.000000 by Gibson Family Trust F1, F3, F4, F11
holding RXRX Stock Option (Right to Buy) 416,350 14 Apr 2022 Class A Common Stock 416,350 $11.40 Direct F7
holding RXRX Stock Option (Right to Buy) 5,436 14 Apr 2022 Class A Common Stock 5,436 $11.40 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $7.61 to $7.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 Represents the conversion of Class B Common Stock into Class A Common Stock.
F4 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F5 This transaction was executed in multiple trades at prices ranging from $7.35 to $7.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $7.36 to $7.60. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F8 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F9 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F11 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.